azd-1152-hqpa and Lymphoma--Large-B-Cell--Diffuse

azd-1152-hqpa has been researched along with Lymphoma--Large-B-Cell--Diffuse* in 1 studies

Other Studies

1 other study(ies) available for azd-1152-hqpa and Lymphoma--Large-B-Cell--Diffuse

Article	Year
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma. Molecular cancer therapeutics, 2019, Volume: 18, Issue:5 Topics: Acetanilides; Animals; Aurora Kinase B; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Nanoparticles; Protein Kinase Inhibitors; Quinazolines; Xenograft Model Antitumor Assays	2019

Article

Year

Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma.

Molecular cancer therapeutics, 2019, Volume: 18, Issue:5

Topics: Acetanilides; Animals; Aurora Kinase B; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Nanoparticles; Protein Kinase Inhibitors; Quinazolines; Xenograft Model Antitumor Assays

2019